FoxP3 rs3761548 polymorphism predicts autoimmune disease susceptibility: A meta-analysis

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1665-1671

  He, Yanqi ^a   Na, Huang ^b   Li, Yalun ^a   Qiu, Zhixin ^a   Li, Weimin ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ALLELE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; DOMINANT INHERITANCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HOMOZYGOSITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84888203362     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.270     Document Type: Review

References (60)

1. Marrack P., Kappler J., Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med 2001, 7:899-905.
2. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun Rev 2003, 2:119-125.
3. Davidson A., Diamond B. Autoimmune diseases. N Engl J Med 2001, 345:340-350.
4. Vyse T.J., Todd J.A. Genetic analysis of autoimmune disease. Cell 1996, 85:311-318.
5. Anaya J.M. The autoimmune tautology. Arthritis Res Ther 2010, 12:147.
6. Anaya J.M. Autoimmunity and autoimmune disease: a Colombian construction beyond deconstructions. Autoimmun Rev 2006, 5:165-166.
7. Anaya J.M., Gomez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13:185-195.
8. Becker K.G. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 2004, 62:309-317.
9. Becker K.G. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?. Diabetes 1999, 48:1353-1358.
10. Song G.G., Choi S.J., Ji J.D., Lee Y.H. Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. Hum Immunol 2012, 74:364-370.
11. Lee Y.H., Song G.G. Associations between TNFSF4 and TRAF1-C5 gene polymorphisms and systemic lupus erythematosus: a meta-analysis. Hum Immunol 2012, 73:1050-1054.
12. Liang Y.L., Wu H., Shen X., Li P.Q., Yang X.Q., et al. Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis. Mol Biol Rep 2012, 39:8873-8882.
13. Lee Y.H., Bae S.C., Song G.G. TNF promoter -308 A/G and -238 A/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis. Mol Biol Rep 2012, 39:8497-8503.
14. Gao L., Li K., Li F., Li H., Liu L., et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010, 57:51-56.
15. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
16. Suri-Payer E., Amar A.Z., Thornton A.M., Shevach E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998, 160:1212-1218.
17. Taylor P.A., Noelle R.J., Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001, 193:1311-1318.
18. Bennett C.L., Brunkow M.E., Ramsdell F., O'Briant K.C., Zhu Q., et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics 2001, 53:435-439.
19. Wang L., Liu R., Li W., Chen C., Katoh H., et al. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 2009, 16:336-346.
20. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
21. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000, 192:303-310.
22. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16:311-323.
23. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001, 276:37672-37679.
24. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545.
25. Bassuny W.M., Ihara K., Sasaki Y., Kuromaru R., Kohno H., et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003, 55:149-156.
26. Park O., Grishina I., Leung P.S., Gershwin M.E., Prindiville T. Analysis of the Foxp3/scurfin gene in Crohn's disease. Ann N Y Acad Sci 2005, 1051:218-228.
27. Fodor E., Garaczi E., Polyanka H., Koreck A., Kemeny L., et al. The rs3761548 polymorphism of FOXP3 is a protective genetic factor against allergic rhinitis in the Hungarian female population. Hum Immunol 2011, 72:926-929.
28. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
29. Inoue N., Watanabe M., Morita M., Tomizawa R., Akamizu T., et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol 2010, 162:402-406.
30. Zhang J., Chen Y., Jia G., Chen X., Lu J., et al. FOXP3 -3279 and IVS9+459 polymorphisms are associated with genetic susceptibility to myasthenia gravis. Neurosci Lett 2012, 534:274-278.
31. Yang S.Y., Gou H., Song Z.Q., Liu B.H., Guo H.W., Song Q.H., et al. Relationship between FOXP3 gene polymorphism and alopecia areata. Immunol J 2012, 26:320-324.
32. Li HX. Relationship between regulatory T cell and FOXP3 gene polymorphism and vitiligo. GT Fourth Military Medical University; 2008, p. 1-100.
33. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
34. Laureti S., Aubourg P., Calcinaro F., Rocchiccioli F., Casucci G., et al. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab 1998, 83:3163-3168.
35. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
36. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
37. Rzany B., Naldi L., Schafer T., Stern R., Williams H. The diagnosis of psoriasis: diagnostic criteria. Br J Dermatol 1998, 138:917.
38. McNeish A.S., Harms H.K., Rey J., Shmerling D.H., Visakorpi J.K., et al. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979, 54:783-786.
39. Alberti K., DeFronzo R.A. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
40. Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66:222-227.
41. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
42. Zhuo W., Zhang L., Zhu B., Qiu Z., Chen Z. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls. PLoS One 2012, 7:e46974.
43. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
44. Qiu M.T., Hu J.W., Ding X.X., Yang X., Zhang Z., et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One 2012, 7:e50887.
45. Liu J., Jia Y.J., Li X.L., Xu R.X., Zhu C.G., et al. RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies. PLoS One 2012, 7:e47211.
46. Parsons B.L., Heflich R.H. Genotypic selection methods for the direct analysis of point mutations. Mutat Res 1997, 387:97-121.
47. Steffensen R., Thiel S., Varming K., Jersild C., Jensenius J.C. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000, 241:33-42.
48. Lang J., Song X., Cheng J., Zhao S., Fan J. Association of GSTP1 Ile105Val polymorphism and risk of head and neck cancers: a meta-analysis of 28 case-control studies. PLoS One 2012, 7:e48132.
49. Takahashi T., Sakaguchi S. Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease. Curr Mol Med 2003, 3:693-706.
50. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
51. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
52. Chattopadhyay S., Chakraborty N.G., Mukherji B. Regulatory T cells and tumor immunity. Cancer Immunol Immunother 2005, 54:1153-1161.
53. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
54. Sakaguchi S., Wing K., Miyara M. Regulatory T cells - a brief history and perspective. Eur J Immunol 2007, 37(Suppl. 1):S116-S123.
55. Fontenot J.D., Gavin M.A., Rudensky A.Y. FoxP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
56. Sanchez E., Rueda B., Orozco G., Oliver J., Vilchez J.R., et al. Analysis of a GT microsatellite in the promoter of the foxp3/scurfin gene in autoimmune diseases. Hum Immunol 2005, 66:869-873.
57. Owen C.J., Eden J.A., Jennings C.E., Wilson V., Cheetham T.D., et al. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006, 37:97-104.
58. Bjornvold M., Amundsen S.S., Stene L.C., Joner G., Dahl-Jorgensen K., et al. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J Autoimmun 2006, 27:140-144.
59. Ban Y., Tozaki T., Tobe T., Jacobson E.M., Concepcion E.S., et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007, 28:201-207.
60. Eastell T., Hinks A., Thomson W. SNPs in the FOXP3 gene region show no association with Juvenile Idiopathic Arthritis in a UK Caucasian population. Rheumatology (Oxford) 2007, 46:1263-1265.